Skip to main content

ADVERTISEMENT

BCMA in MM

Kevin Boyd, PhD, on the Safety, Efficacy of Belantamab Mafodotin With B-Vd for R/R MM
Videos
12/29/2020
Dr Boyd highlights details of the phase 3 DREAMM-7 trial, examining the efficacy and safety of belantamab mafodotin with bortezomib and dexamethasone for relapsed/refractory MM.
Dr Boyd highlights details of the phase 3 DREAMM-7 trial, examining the efficacy and safety of belantamab mafodotin with bortezomib and dexamethasone for relapsed/refractory MM.
Dr Boyd highlights details of...
12/29/2020
Oncology
Paul Richardson, MD, Discusses Belantamab Mafodotin for Relapsed/Refractory MM
Conference Insider
12/10/2020
Dr Richardson discusses belantamab mafodotin for targeting BCMA pathways in relapsed/refractory MM, and the DREAMM-5 trial of 4 novel combo therapies for this disease.
Dr Richardson discusses belantamab mafodotin for targeting BCMA pathways in relapsed/refractory MM, and the DREAMM-5 trial of 4 novel combo therapies for this disease.
Dr Richardson discusses...
12/10/2020
Oncology